MacroGenics
MGNX
124 hedge funds and large institutions have $495M invested in MacroGenics in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 21 closing their positions.
355% more call options, than puts
Call options by funds: $6.28M | Put options by funds: $1.38M
66% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 32
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 21
2.13% less ownership
Funds ownership: 95.04% → 92.91% (-2.1%)
2% less funds holding
Funds holding: 127 → 124 (-3)
17% less capital invested
Capital invested by funds: $593M → $495M (-$98M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.85M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$7.4M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$5.86M |
| 4 |
D.E. Shaw & Co
New York
|
+$3.56M |
| 5 |
PA
Pinnacle Associates
New York
|
+$3.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$10M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$9.35M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$9.3M |
| 4 |
Millennium Management
New York
|
-$8.21M |
| 5 |
6CM
683 Capital Management
New York
|
-$5.1M |
MGNX Hedge Fund Activity: Q4 2019 in Review
124 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2019, worth a combined $495M — down 17% from $593M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of MGNX and 19 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 53 added.
The largest buyer was Wasatch Advisors, adding an estimated $7.85M. The largest seller was GMT Capital, cutting an estimated $10M.
- 124 institutional investors held MacroGenics (MGNX) as of Q4 2019, down from 127 in Q3 2019.
- Funds reported $495M of MacroGenics stock for Q4 2019, down 17% quarter-over-quarter.
- 19 funds opened new MacroGenics positions in Q4 2019 and 21 closed out, a net change of -2 holders.
- The largest MacroGenics buyer in Q4 2019 was Wasatch Advisors, an estimated $7.85M added.
- The largest MacroGenics seller in Q4 2019 was GMT Capital, an estimated $10M sold.
Based on aggregated 13F filings for Q4 2019.